NOVIFIT® (NoviSAMe®) tablets improve executive function in aged dogs and cats: Implications for treatment of cognitive dysfunction syndrome

International Journal of Applied Research in Veterinary Medicine

Volumn 10, Issue 1, 2010, Pages 90-98

  Araujo, Joseph A ^a,b,c   Faubert, Marjorie L ^d   Brooks, Melissa L ^d   Landsberg, Gary M ^a,e   Lobprise, Heidi ^f  

^a CanCog Technologies Incorporated   (Canada)

^b InterVivo Solutions Inc   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d VivoCore Inc   (Canada)

^e North Toronto Animal Clinic   (Canada)

^f Virbac Corporation   (United States)

Author keywords

Aging; Cognitive dysfunction syndrome; Executive function; Memory performance; S adenosylmethionine; Senior pet care

Indexed keywords

ANIMALIA; CANIS FAMILIARIS; FELIDAE;

EID: 84862561041     PISSN: 15422666     EISSN: 1559470X     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Association of Feline Practitioners. Senior Care Guidelines Revised December 2008.
2. Hempel H, Prvulovic D, et al. The future of Alzheimer's disease: The next 10 years. Prog Neurobiol. 2011;95:718-728.
3. Cotman CW, Head E. The canine (dog) model of human aging and disease: dietary, environmental and immunotherapy approaches. J Alzheimers Dis. 2008;15,685-707.
4. Landsberg G, Denenberg S, Araujo J. Cognitive dysfunction in cats: A syndrome we used to dismiss as 'old age'. J Fel Med Surg. 2010;12:837-848.
5. Landsberg GM, DePorter T, Araujo JA. Clinical signs and management of anxiety, sleeplessness, and cognitive dysfunction in the senior pet. Vet Clin N Am Small Anim Prac. 2011;41:565-590.
6. Peijun C, Ratcliff G, et al. Patterns of cognitive decline in presymptomatic Alzheimer diease. 2001;58:853-858.
7. Araujo JA, Chan ADF, et al. Dose-specific effects of scopolamine on canine cognition: Impairment of visuospatial memory, but not visuospatial discrimination. Psychopharmacology. 2004;175:92-98.
8. Pan Y, Larson B, et al. Dietary supplementation with medium-chain TAG has long-lasting cognition-enhancing effects in aged dogs. Br J Nutr 2010;103:1746-1754.
9. Milgram NW, Landsberg GM, et al. Age and Cognitive dysfunction in the domestic cat. In: Proceedings of the ACVB/AVSAB Symposium. St. Louis: 2011, p. 28-29.
10. Tapp PD, Siwak CT, et al. Size and reversal learning in the beagle dog as a measure of executive function and inhibitory control in aging. Learn Mem. 2003;10:64-73.
11. Studzinski CM, Christie LA, et al. Visuospatial function in the beagle dog: an early marker of cognitive decline in a model of human aging and dementia. Neurobiol Learn Mem. 2006;86:197-204.
12. Snigdha S, de Rivera C, et al. Age and distraction are determinants of performance on a novel visual search task in Beagle dogs. AGE. (Epub Feb 2011).
13. Tapp PD, Siwak CT, et al. Frontal lobe volume, function, and beta-amyloid pathology in a canine model of aging. J Neurosci 2004;24:8205-8213.
14. Head E, McCleary R, et al. Region-specific age at onset of beta-amyloid in dogs. Neurobiol Aging. 2000;21:89-96.
15. Bottiglieri T. S-adenosyl-l-methionine (SAMe): From the bench to bedside - molecular basis of a pleiotrophic molecule. Am J Clin Nutrition 2002;76:1151S-1157S.
16. Panza F, Frisardi V, et al. Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predmentia syndromes and Alzheimer's disease: A review. Scientifc World J. 2009;9:373-389.
17. De La Cruz JP, Pavia J, et al. Effects of chronic administration of S-adenosyl-l-methionine on brain oxidative stress. Naunyn-Schmiedebergs Arch Pharmacol. 2000;361:47-52.
18. Flora GJ, Seth PK. Beneficial effects of S-adenosyl-l-methionine on aminolevulinic acid dehydratase, glutathione, and lipid peroxidation during acute lead-ethanol administration in mice. Alcohol. 1999;18:103-108.
19. Villalobos MA, De La Cruz, et al. Effect of S-adenosyl-l-methionine on rat brain oxidative stress damage in a combined model of permanent focal ischemia and global ischemia-repurfusion. Brain Res. 2000;883:31-40.
20. Chan A, Tchantchou F, et al. Dietary deficiency increases presenilin expression, gamma-secretase acticvty, and Abeta levels: Potentiation by ApoE genotype and alleviation by S-adenosyl methio-nine. J Neurochem. 2009;110:831-836.
21. Linnebank M, Pop J, et al. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease. Neurodegen Dis. 2010;7:373-378.
22. Rème CA, Dramard V, et al. Effect of S-adenosyl-methionine tablets on the reduction of age-related mental decline in dogs: a double-blind placebo-controlled trial. Vet Ther. 2008;9:69-82.
23. Milgram NW, Head E, et al. Cognitive functions and aging in the dog: acquisition of nonspatial visual tasks. Behav Neurosci. 1994;108:57-68.
24. Araujo JA, Studzinski CM, et al. Assessment of nutritional interventions for modifcation of age-associated cognitive decline using a canine model of human aging. AGE. 2005;27:27-37.
25. Milgram NW, Head E, et al. Long-term treatment with antioxidants and a program of behavioral enrichment reduces age-dependent impairment in discrimination and reversal learning in beagle dogs. Exp Gerontol. 2004;39:753-65.
26. Head E. Combining an antioxidant-fortified diet with behavioral enrichment leads to cognitive improvement and reduced brain pathology in aging canines: strategies for healthy aging. Ann N Y Acad Sci. 2007;1114:398-406.